低剂量的NSAIDs和sysadoas在膝关节关节炎的管理中
Alberto Migliore1, Orazio De Lucia2, Alessandro de Sire3,4
1Rheumatology Unit, San Pietro Fatebenefratelli Hospital, Rome, Italy.
Aging clinical and experimental research
|November 6, 2025
概括
低剂量迪克洛菲纳克与氏丁硫酸盐相结合,在治疗膝关节骨关节炎 (OA) 方面显示出有前途. 这种组合可以减少疼痛和改善功能,可能降低NSAID副作用.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎 (OA) 是一种使人虚弱的关节疾病,影响软骨,骨和突.
- 有效的长期关节炎管理具有挑战性,目前的治疗方法主要集中在症状控制上.
研究的目的:
- 评估低剂量二二和地硫酸盐对OA的联合疗效,安全性和临床效用.
- 评估这种组合在膝关节OA管理中的潜在作用.
主要方法:
- 系统的文献审查.
- 结构化Delphi调查与一个由OA专家组成的国际技术专家小组 (TEP).
主要成果:
- 专家的共识表明,这种组合可以有效地减少疼痛,并改善膝关节OA患者的关节功能.
- 这种治疗方法可以减少对高剂量的NSAID的依赖,减轻系统性不良影响.
结论:
- 低剂量二二和二丁硫酸盐组合是一种潜在的治疗策略,用于膝关节OA.
- 需要进一步的研究来验证发现并优化治疗以改善患者的治疗结果.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
413
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
413
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
869
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
869
Rheumatic Heart Disease III: Medical Management
261
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
261
Inflammatory Bowel Disease IV: Pharmacological Management
427
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
427
Atherosclerosis III: Management
290
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
290
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K


